Gerresheimer AG
XETRA:GXI
Gerresheimer AG
XETRA:GXI
Price:
94.6 EUR
-3.86%
Market Closed
Updated:
May 21, 2024
Gerresheimer AG
Interest Income Expense
|
Gerresheimer AG
Interest Income Expense Peer Comparison
Comparables:
E
EVT
S
1SXP
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gerresheimer AG
XETRA:GXI
|
Interest Income Expense
-€48.3m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-3%
|
|
E
|
Evotec SE
XETRA:EVT
|
Interest Income Expense
-€32.4m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-30%
|
|
S
|
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
|
Interest Income Expense
€16.7m
|
CAGR 3-Years
68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Gerresheimer AG's Interest Income Expense?
Interest Income Expense
-48.3m
EUR
-48.3m
EUR
Based on the financial report for Feb 29, 2024, Gerresheimer AG's Interest Income Expense amounts to -48.3m EUR.
What is Gerresheimer AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-3%
-3%
Over the last year, the Interest Income Expense growth was -51%. The average annual Interest Income Expense growth rates for Gerresheimer AG have been -35% over the past three years , -14% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
